BriaCell Therapeutics's total assets for Q2 2026 were C$45.49M, an increase of 247.93% from the previous quarter. BCTX total liabilities were C$4.58M for the fiscal quarter, a 22.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.